Study Investigating the determinants of skeletal fragility in patients with predisposing conditions.
The SINTER Study (eraSmus medIcal ceNTer skEletal fRagility (SINTER) Studie) is led by Erasmus MC and conducted by a team of doctors, researchers, and nurses across different outpatient clinics.
The study includes both healthy individuals and patients and is divided into two phases. It aims to recruit 5,650 participants from eight outpatient clinics:
This study compares bone strength between two groups:
The study aims to combine genetic data with physical and nutritional assessments to better understand what affects bone strength. By looking at both genetic and physical factors, researchers hope to discover new biological reasons why some people have stronger bones than others. This could lead to more personalized ways to prevent and treat weak bones (skeletal fragility).
Additionally, the study will explore participants’ experiences and opinions on genetic research in bone health. This will help future studies be more effective while considering participants’ needs and concerns.
Bone strength refers to how strong and durable bones are. It mainly depends on:
Keeping bones strong is crucial for staying active and healthy as we age. Weak bones can lead to fractures, mobility issues, and even serious health problems.
Doctors use DXA scans to measure bone mineral density (BMD) and diagnose conditions like osteoporosis.
Bone strength varies due to several factors:
Because many factors contribute to bone strength, current medical tools may not fully predict who is at risk for fractures.
While aging, lifestyle, and diseases influence bone strength, they don’t explain why some people are more prone to fractures than others. This suggests that genetics plays an important role.
Everyone’s DNA contains many small genetic variations that, when combined, can affect bone strength. By studying these variations, scientists can calculate a polygenic risk score (PRS)—a measure of genetic risk for weak or strong bones.
Researchers compare people with genetically predicted low and high BMD to understand the biological mechanisms behind bone strength. However, genetics is only one piece of the puzzle. Lifestyle factors like exercise and diet can also influence actual bone strength, sometimes overriding genetic predictions.
If neither genetics nor lifestyle fully explains someone’s bone density, researchers may look for rare genetic mutations that could be affecting bone strength in unexpected ways.
If you take part in both Stage 1 and Stage 2, you will have two appointments:
The entire study can take up to 18 months.
Before joining, we need to check if you qualify.
✔ Be 18 years or older
✔ Be a patient at Erasmus MC in one of these clinics: diabetes, kidney, geriatric, vascular medicine, healthy weight, bone center, or mastocytosis
✔ Agree to an extra blood sample during your routine care
✔ Be mentally able to give consent or have a legal representative
✔ Be willing to return for further tests if selected for Stage 2
✔ Have a genetic score showing “low” or “high” bone mineral density
✔ Not be pregnant
If your genetic results classify you as having “low” or “high” predicted bone density, you will be invited for a 90-minute visit at the Erasmus Rotterdam Gezondheid Onderzoek (ERGO) research center.
– EOS Edge Imaging – A special scan that takes high-quality images of your bones while you stand, providing a clearer picture of your skeletal structure. It’s quick, producing 2D and 3D images in seconds.
These tests help us better understand bone strength and potential risks of fractures.
Genecraft © 2025. All rights reserved.
| Build by Creative Corner
Disclaimer | Privacy | Cookies